Avid uptake of [18F]-FDG in fibrous dysplasia can mimic skeletal involvement in Hodgkin's disease

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 1, 2008, Pages 223-

  Von Falck, C ^a   Rosenthal, H ^a   Laenger, F ^a   Lotz, J ^a   Knapp, W H ^a   Galanski, M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ARTICLE; BONE BIOPSY; BONE METASTASIS; CANCER CHEMOTHERAPY; CASE REPORT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FIBROUS DYSPLASIA; HODGKIN DISEASE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; SCHOOL CHILD; BONE; CHILD; METABOLISM; PATHOLOGY;

BONE AND BONES; CHILD; DIAGNOSIS, DIFFERENTIAL; FIBROUS DYSPLASIA, MONOSTOTIC; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MALE;

EID: 36849065220     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0566-3     Document Type: Article

References (3)

1. DiCaprio MR, Enneking WF. Fibrous dysplasia. J Bone Joint Surg Am 2005;87:1848-64.
2. Kao CH, Sun SS, Shen YY, Chen YK. Misdiagnosis of multiple bone metastases due to increased FDG uptake in polyostotic fibrous dysplasia. Clin Nucl Med 2007;32:409-10.
3. Strobel K, Bode B, Lardinois D, Exner U. PET-positive fibrous dysplasia - a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery. Skeletal Radiol 2007;36 S1:24-8.